Bjoern Peters Selected Research

Epitopes

7/2022	Immunodominant MHC-II (Major Histocompatibility Complex II) Restricted Epitopes in Human Apolipoprotein B.
2/2022	Combined assessment of MHC binding and antigen abundance improves T cell epitope predictions.
1/2021	SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19.
1/2021	Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases.
1/2021	The Cancer Epitope Database and Analysis Resource: A Blueprint for the Establishment of a New Bioinformatics Resource for Use by the Cancer Immunology Community.
12/2020	Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases.
1/2020	Epitope-specific airway-resident CD4+ T cell dynamics during experimental human RSV infection.
1/2020	The Immune Epitope Database and Analysis Resource Program 2003-2018: reflections and outlook.
1/2020	Epitope prediction and identification- adaptive T cell responses in humans.
1/2020	Restricted myeloperoxidase epitopes drive the adaptive immune response in MPO-ANCA vasculitis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bjoern Peters Research Topics

Disease

39	Infections 10/2021 - 09/2005
29	Hypersensitivity (Allergy) 01/2022 - 03/2007
18	Neoplasms (Cancer) 02/2022 - 09/2009
13	COVID-19 05/2022 - 01/2020
12	Communicable Diseases (Infectious Diseases) 01/2020 - 03/2007
9	Tuberculosis (Tuberculoses) 12/2021 - 05/2012
9	Asthma (Bronchial Asthma) 12/2020 - 08/2012
8	Malaria 09/2021 - 04/2010
8	Dengue (Dengue Fever) 01/2018 - 01/2015
7	Whooping Cough (Pertussis) 11/2021 - 05/2014
7	Smallpox (Variola) 05/2016 - 09/2005
5	Inflammation (Inflammations) 03/2022 - 09/2012
5	Vaccinia 01/2022 - 09/2005
5	Parkinson Disease (Parkinson's Disease) 11/2021 - 01/2017
5	Human Influenza (Influenza) 02/2016 - 01/2007
4	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 10/2009
4	Congenital Heart Defects (Congenital Heart Defect) 08/2014 - 01/2009
4	Aortic Coarctation 10/2008 - 10/2004
3	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2019
3	Virus Diseases (Viral Diseases) 01/2016 - 08/2008
2	Atherosclerosis 07/2022 - 01/2020
2	Vasculitis (Vasculitides) 01/2022 - 01/2020
2	Carcinogenesis 01/2022 - 01/2021
2	Severe Dengue 01/2019 - 08/2015
2	Rhinitis 01/2018 - 08/2012
2	Drug-Related Side Effects and Adverse Reactions 01/2015 - 06/2012
2	HIV Infections (HIV Infection) 07/2010 - 11/2005
2	Arenaviridae Infections 06/2010 - 05/2010
2	Aseptic Meningitis 05/2010 - 12/2009
2	Fever (Fevers) 05/2010 - 12/2009
2	Lymphocytic Choriomeningitis 05/2010 - 12/2009
2	Aneurysm (Aneurysms) 01/2009 - 04/2006
2	Pathologic Constriction (Stenosis) 05/2008 - 10/2004
1	Coronary Artery Disease (Coronary Atherosclerosis) 07/2022
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 05/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Myocarditis (Carditis) 01/2022
1	Disease Progression 11/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021

Drug/Important Bio-Agent (IBA)

62	EpitopesIBA 07/2022 - 09/2005
41	VaccinesIBA 01/2022 - 09/2005
35	AntigensIBA 01/2022 - 09/2005
25	Peptides (Polypeptides)IBA 01/2022 - 09/2005
22	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 07/2022 - 09/2005
20	Proteins (Proteins, Gene)FDA Link 03/2022 - 09/2005
14	AllergensIBA 01/2021 - 09/2009
8	AutoantigensIBA 11/2021 - 09/2005
6	CytokinesIBA 07/2022 - 07/2006
6	HLA Antigens (Human Leukocyte Antigens)IBA 01/2017 - 02/2010
4	HLA-B57 antigenIBA 01/2022 - 01/2015
4	abacavir (Ziagen)FDA Link 01/2022 - 01/2015
4	SynucleinsIBA 11/2021 - 01/2017
4	AntibodiesIBA 01/2020 - 12/2009
4	Immunoglobulin E (IgE)IBA 01/2018 - 07/2012
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2019
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 11/2012
3	Pharmaceutical PreparationsIBA 01/2015 - 06/2012
2	Apolipoproteins B (ApoB)IBA 07/2022 - 01/2020
2	LigandsIBA 02/2022 - 11/2017
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 01/2020
2	Interferon-gamma (Interferon, gamma)IBA 01/2022 - 02/2016
2	BNT162 VaccineIBA 03/2021 - 01/2021
2	COVID-19 VaccinesIBA 03/2021 - 01/2021
2	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 01/2021 - 03/2007
2	Subunit VaccinesIBA 01/2021 - 05/2014
2	Acellular VaccinesIBA 01/2021 - 05/2014
2	HLA-DR Antigens (HLA-DR)IBA 01/2021 - 10/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2014
2	Viral AntigensIBA 01/2020 - 12/2015
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2013
2	Attenuated VaccinesIBA 12/2017 - 01/2017
2	Isoantigens (Alloantigen)IBA 01/2017 - 10/2012
2	Nevirapine (Viramune)FDA Link 01/2017 - 01/2015
2	Interleukin-2 (IL2)IBA 11/2016 - 11/2010
2	HLA-DRB1 Chains (HLA DRB1)IBA 10/2016 - 02/2010
2	Antiviral Agents (Antivirals)IBA 05/2015 - 03/2010
2	Histones (Histone)IBA 08/2014 - 09/2012
2	Hemagglutinins (Hemagglutinin)IBA 05/2014 - 01/2007
2	Coenzyme A (CoA)IBA 10/2008 - 04/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2022
1	Inosine Triphosphate (ITP)IBA 05/2022
1	CholesterolIBA 03/2022
1	ChemokinesIBA 03/2022
1	SARS-CoV-2 spike proteinIBA 01/2022
1	Myeloblastin (Proteinase 3)IBA 01/2022
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2022
1	mRNA VaccinesIBA 01/2022
1	Biological ProductsIBA 01/2021
1	EnzymesIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Inactivated VaccinesIBA 01/2021
1	InterferonsIBA 12/2020
1	Interleukin-9 (Interleukin 9)IBA 12/2020
1	BCG Vaccine FDA Link 10/2020

Therapy/Procedure

9	Therapeutics 10/2021 - 10/2004
8	Immunotherapy 01/2022 - 08/2012
6	Transplantation 01/2020 - 09/2009
6	Stents 03/2010 - 10/2004
1	Chemoprevention 12/2021